Desvenlafaxine (Pristiq): A Potential Off-Label Treatment for Migraine

Desvenlafaxine (Pristiq): A Potential Off-Label Treatment for Migraine

Cerebral Torque

Click for the full list of the 50 uncommon migraine preventives

What is Desvenlafaxine?

Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). Therefore, it inhibits the reuptake of serotonin and norepinephrine.

Desvenlafaxine is also a metabolite of venlafaxine, another SNRI, which we talked about previously and is also on the list of uncommon migraine preventives. So what is the difference between the two? Desvenlafaxine is more potent than venlafaxine. 

Desvenlafaxine is a prescription medication that is FDA-approved to treatment of major depressive disorder (MDD). It is sometimes used as an off-label migraine preventive as an alternative to venlaxafine. 

How Does Desvenlafaxine Work?

Desvenlafaxine works by inhibiting the reuptake of serotonin and norepinephrine thereby increasing their levels in the brain. Desvenlafaxine has more affinity to the norepinephrine reuptake inhibitor and, thus, allows for an increased concentration of norepinephrine than serotonin. We do not know if this benefits migraine patients yet because there are no studies. 

Desvenlafaxine as a Potential Treatment Option for Migraine

There is currently no research available for desvenlafaxine and migraine prevention, but because it is a potent metabolite of venlafaxine, we assume that the studies for venlafaxine may be applied. 

In one study published in the Journal of Head and Face Pain, venlafaxine was found to be more effective than placebo and safe as a migraine preventive. 

Source

In a randomized, double-blind, crossover study, venlafaxine was found to have similar efficacy and less adverse effects when compared to a common firs-line migraien preventive amitriptyline

Source

Potential Side Effects of Desvenlafaxine

Common side effects of desvenlafaxine include nausea, headache, dry mouth, insomnia, and constipation. If you experience any severe side effects or have concerns about taking this medication, it is important to speak with your healthcare provider.

There is an FDA black box warning against desvenlafaxine as it can increase suicidality, cause depression exacerbation, hypomania/mania, and serotonin/neuroleptic malignant syndrome.

Other Considerations for Desvenlafaxine

Desvenlafaxine comes in a tablet that is 50 mg or 100 mg. It cannot be split so one cannot titrate up or wean off. It is also more expensive than venlafaxine. 

Do not use desvenlafaxine if you have used an MAO inhibitor in the past 14 days.

Risk of serotonin syndrome if used with triptans, but unlikely. Speak to your healthcare provider.

This is a cursory understanding of uncommon migraine medications. This is only to be used as a resource to go to your neurologist with. 

Back to blog
  • Global Migraine Trends Analysis

    Global Migraine Trends Analysis

    Cerebral Torque

    A comprehensive 30-year analysis reveals that migraine affects approximately 1 in 7 people globally, with cases increasing by 58% between 1990 and 2021. While women show higher overall prevalence, men's...

    Global Migraine Trends Analysis

    Cerebral Torque

    A comprehensive 30-year analysis reveals that migraine affects approximately 1 in 7 people globally, with cases increasing by 58% between 1990 and 2021. While women show higher overall prevalence, men's...

  • How Migraine Medications Are Tested

    How Migraine Medications Are Tested

    Cerebral Torque

    Ever wondered how migraine medications are proven safe and effective? This is the article for you.

    How Migraine Medications Are Tested

    Cerebral Torque

    Ever wondered how migraine medications are proven safe and effective? This is the article for you.

  • Resistant migraine (ResM) Vs Refractory migraine (RefM) Vs Non-resistant/non-refractory migraine (NRNRM)

    Resistant migraine (ResM) Vs Refractory migrain...

    Cerebral Torque

    The REFINE study showed that resistant migraine (ResM) and refractory migraine (RefM) represent distinct clinical entities with progressively increasing burden of comorbidities (Table 1). 

    Resistant migraine (ResM) Vs Refractory migrain...

    Cerebral Torque

    The REFINE study showed that resistant migraine (ResM) and refractory migraine (RefM) represent distinct clinical entities with progressively increasing burden of comorbidities (Table 1). 

  • Aura Characteristics in Migraine Disease

    Aura Characteristics in Migraine Disease

    Cerebral Torque

    Understanding Migraine with Aura A study published in Cephalalgia sheds new light on migraine with aura (MwA), examining data from 272 patients across Italian headache centers. The research reveals that...

    Aura Characteristics in Migraine Disease

    Cerebral Torque

    Understanding Migraine with Aura A study published in Cephalalgia sheds new light on migraine with aura (MwA), examining data from 272 patients across Italian headache centers. The research reveals that...

1 of 4